Peptide and Protein Technology
Product Description
Almac Group
-
Country/Region:United Kingdom
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
.jpg)
Categories
Almac Group
-
Country/Region:United Kingdom
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
More Products from Almac Group (18)
-
Product 14C Radiolabelling
We provide stable isotope and 14C radiolabelling services to support programmes from drug discovery through to commercialisation. We can label small molecules, peptides and larger biomolecules, backed by integrated analytical, QC and regulatory expertise. Our MHRA-certified facilities support 14C IMP manuf... -
Product Analytical Services
With more than 55 years of experience, we provide comprehensive analytical support across the drug development lifecycle, from early pre-clinical development through to commercial release. Our expert teams develop over 1,000 analytical methods and validate more than 250 methods annually. Combining advanced... -
Product Biocatalysis Solutions
Biocatalysis offers a highly selective and efficient approach to the synthesis of complex pharmaceutical and fine chemical targets, including challenging chiral molecules. As the adoption of biocatalysts continues to grow across the industry, Almac Sciences has invested significantly in biocatalysis capabi... -
Product Commercial Packaging
We offer a wide range of commercial packaging solutions to meet your needs, from initial artwork and pack design, to commercial packaging and distribution.
From our UK and US commercial packaging facilities, we are able to serve global markets. We are MHRA and FDA licensed an... -
Product Complex Kit Assembly
We provide flexible complex kit assembly solutions, from low-volume manual kitting to high-volume semi-automated commercial packaging. Enhanced by investment in our US packaging facility, we support the specialised assembly of medical devices, combination products, biologics and pharmaceutical kits. Our cu... -
Product Commercial Storage and Distribution
Complementing our commercial manufacturing and packaging services, we provide a range of commercial storage and distribution solutions for solid oral dosage forms and sterile biopharmaceuticals, for both niche / orphan drug products and large scale commercial market volumes.
Utilising our bespok... -
Product Pharmaceutical Development - Early Phase
Almac’s experienced formulation scientists can develop a range of oral dose formulations for early stage clinical trials.
With both non-GMP and GMP facilities, flexible and efficient solutions are provided to develop a fit-for-purpose formulation for your early phase clinical trial.
... -
Product Pharmaceutical Development - Late Phase
Enabling Confidence and Security in the Supply Chain
Specialising in solid oral dosage forms, Almac has the technical experience and knowledge to develop robust formulations and manufacturing processes.
We have assisted many of our clients in the development of both immediate and mo... -
Product Pharmaceutical Product Launch and Distribution
Pharmaceutical Product Launch and Distribution
Having successfully partnered in the launch of 15 significant orphan and niche drug products into the EU market over the last 3 years, Almac is the industry leader for Pharmaceutical Product Launch and Distribution.
q... -
Product Large Scale Intermediates
Our manufacturing range includes fine chemical products for diverse industrial applications and features a range of pharmaceutical intermediates, flavour & fragrance and other personal care products and specialities (including bulk supply of monomers) and chiral amino acids. Specialised products ... -
Product Bioavailability enhancement
With a fully integrated, unified approach from pre-formulation development to GMP manufacturing, we help maximise drug product potential by enhancing solubility, stability and therapeutic effect.
-
Product Commercial Drug Product Manufacture
Large scale GMP manufacture of oral dose product including potent and highly potent.
Almac Group resources (47)
-
News Almac Pharma Services Opens Doors on £65m New Commercial Manufacturing Facility
The 100,000sq ft facility not only expands our range of capabilities, but also reinforces our position as an industry leader in pharmaceutical development and commercial manufacturing with an ability to tailor our services to suit individual products. -
Brochure Think Almac Sciences
Your integrated API and analytical services provider -
News Almac Group Expands Bioavailability Enhancement Capabilities
The 100,000sq ft facility not only expands our range of capabilities, but also reinforces our position as an industry leader in pharmaceutical development and commercial manufacturing with an ability to tailor our services to suit individual products. -
Brochure Ultra-Low Temperature Packaging & Distribution Solutions
With more than 50 years’ experience, we offer a wide range of specialised packaging solutions to meet, and deliver your product launch and ongoing commercial needs. -
News Almac Group Expands US Analytical Capacity with New Stability Chambers in Souderton, PA
Almac Group has announced the official opening of new GMP-qualified analytical stability chambers and office space at its US Headquarter campus in Souderton, Pennsylvania. This $2 million investment builds on the multi-million-dollar expansion of global analytical services and reinforces Almac’s commitment to meeting growing client demand. -
Brochure Tailor-made Product Launch Solutions
Balancing speed with precision, our flexible suite of offerings provides you with a reliable, effective, and expert approach to support the successful and timely introduction and launch of your new product and market penetration into new territories. -
News Almac invests £500,000 in state-of-the-art instrumentation within spectroscopy laboratories
Almac Sciences, a member of the Almac Group, has invested £500,000 in state-of-the-art instrumentation within its spectroscopy laboratories at its global headquarters in Craigavon, Northern Ireland. -
Brochure Almac Pharmaceutical Development
Our product development service spans early to late phase clinical programs, offering technical experience and dedicated project management, and a track record of on-time delivery from state-of-the-art facilities. -
News Almac chemist recognised as “Future Leader” at CPHI Celebration Awards 2024
Dr Megan Smyth wins award for rising stars bringing fresh approaches in the pharma industry -
Brochure Think Almac...Radiolabelling
Non-GMP & GMP stable & radiolabelling expertise14C labelling of drug substance for human AME studies
Stable & radiolabelled metabolite synthesis
Specialist expertise in peptide & bioconjugate 14C labelling
QC, Analytical & QA integration
MHRA regulatory approved for 14C GMP manufactureof drug substance -
News Almac Group announces £11m investment to expand global analytical services
Almac Group, the global contract development and manufacturing organisation (CDMO), has today announced an £11m investment and the creation of over 100 new jobs to expand global analytical services capabilities. -
Brochure Think Almac...Superior peptide solutions
Over 30 years’ experience in peptide manufactureRapid throughput, high quality manufacture
Customised supply plan for your project needs
Free consultation on peptide design & manufacturability
Smooth transition to scale-up & cGMP manufacture
Strong emphasis on project management & customercare throughout project lifetime -
News Almac Sciences awarded Life Sciences Innovative Manufacturing Fund Grant
Grant awarded to support the expansion of Almac’s small molecule API manufacturing plant -
Brochure Think Almac...Preformulation development
As a world leader in pharmaceutical services, Almac delivers early formulation development workprograms for DRF/PK/tox studies. Designed to maximise solubility and bioavailability withoutcompromising on chemical stability, the studies accelerate drug development to the clinic and minimizerisk in any downstream activities. Almac offer bespoke work packages specifically tailored to thephysiochemical properties of the API (BCS class II, III, or IV) for solubility or permeability enhancement. -
News Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
Tonmya™ is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia, supported by positive results from two Phase 3 studies
New Drug Application (NDA) submission to the FDA planned for second half of 2024
-
Brochure Think Almac...Crystallisation process development
As a world leader in pharmaceutical services, Almac deliversbespoke crystallisation development work programs for smallmolecules and peptides designed to provide a robust, scaleable,and transferrable crystallisation procedure to help accelerateclinical development and minimise risk in any downstreamactivities by eliminating batch-to-batch variability -
News Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity at Headquarters with Two New Purpose-Built Facilities
The Almac Group has today announced the completion of two new purpose-built facilities at its headquarters in Craigavon, Northern Ireland meeting client demand in commercial manufacturing and packaging as well as peptide production.
-
Brochure Think Almac...Solid form screening
As a world leader in pharmaceutical services, Almac delivers unrivalled polymorph,salt, co-crystal, and early crystallisation work programs designed to identify the mostdevelopable solid form of your API to help accelerate development to the clinic andminimise risk in any downstream activities. -
News Almac Group opens a new custom-built GMP warehouse at its Global Headquarters
The new custom-built facility will consolidate the existing warehouses to support all manufacturing and laboratory activities. -
Brochure Think Almac...cGMP peptide manufacture
Expertise in long peptides, radiopharmaceutical precursors & peptide cocktailsSolid phase & liquid phase synthesis
Experience in conjugation to a wide range of chemical entities
Strong project management culture
Full support from in-house analytical & QA teams, & for CMC section preparation -
News Almac Group Wins Life Sciences Team of the Year
Almac Sciences’ Technology Group was selected as the winner of the “Life Sciences Team of the Year” category during this year’s Irish Life Sciences Awards ceremony, held on 6 July 2023 at Crowne Plaza Hotel, Dublin.. -
Brochure Think Almac...Integrated flow technologies
Almac has the expertise andcapabilities to deliver flowtechnologies from proof ofconcept reaction validitythrough to manufacture withdefined workflows -
News Almac Sciences and University College Dublin BROADEN Continuous Flow Chemistry Collaboration
Strengthened collaboration with University College Dublin (UCD) that will focus on the development of novel continuous flow protocols for accessing new industrially relevant drug targets. -
Brochure Think Almac...selectAZyme
Almac’s biocatalysis expertise ranges from enzyme discovery, enzyme engineeringand enzyme production to the synthesis of complex chiral intermediates andactive ingredients, all based on selectAZymeTM technology. Challenge us with yourchemistry problems and see how we can successfully deliver biocatalysis solutionsand more... -
News Almac Group Awarded with Six CDMO Leadership Awards Across all Core Categories
Overall recognition received for compatibility, expertise, quality and reliability. -
Brochure Think Almac...Integrated enzyme technologies
At Almac we have the expertise and capabilities to deliver enzyme technologies from their discovery through to commercial enzyme supply -
News Almac Group secures HPRA certification for biologics testing
Health Products Regulatory Authority (HPRA) has certified Almac Sciences Ireland (ASI) facility for testing of biologics after a successful audit -
Brochure Think Almac...Analytical solutions for biologics
Providing comprehensive and flexible analytical solutions toaccelerate the development and approval of biologics -
News Almac Group Completes First Stage of GMP API Facility Expansion
Expanded GMP manufacturing facility now operational for use in clinical and / or commercial manufacturing -
Brochure Think Almac...Analytical Services
Drawing upon our vast pool of scientific knowledge, we greatly reduce the analytical challenges that typically arise during drug development. -
Video Almac Sciences
Almac Sciences offers services including API development & manufacture, radiolabelling, biocatalysis solutions, peptides & protein technology, pre-formulation, solid state and analytical services. -
Brochure Powder in Bottle Solutions
Scaling up from our development services to full scale commercial drug productmanufacture or transferring existing commercial products, Almac Pharma Servicescan meet your commercial drug product manufacturing requirements.Our range of commercial scale dry blending, and wet and dry granulation technologysupports the commercial drug product manufacture of granules and oral powders forreconstitution. -
Brochure Paediatric Packaging Solutions
With over 50 years’ experience in providing packaging solutions, we understand theunique requirements for paediatric medication packaging. Almac’s comprehensiverange of paediatric packaging options ensures safety, convenience, and adherence toregulatory standards for children’s medications. -
Video Almac Sciences and Pharma Services Overview Video
At Almac, out integrated CMC approach connects API development, analytical expertise, formulation development and clinical supply capabilities through a single, collaborative team. By aligning scientific knowledge across the development pathway, we help reduce complexity, accelerate decision-making and support smoother progression from early development to clinical manufacture. -
Brochure Almac Pharma Services Overview Brochure 2026
Tailor-made product development and commercial solutions. -
Brochure Almac Pharma Services - Our Expertise
Tailor-made product development, manufacture & commercial solutions -
Brochure Paediatric Drug Development and Manufacture brochure
With a wealth of experience in paediatric medication, we understand the unique challenges faced in developing, manufacturing and packaging treatment specifically tailored for young patients. Offering comprehensive solutions which ensure the safety, efficacy, and appropriate dosing of medications for children. We recognise that paediatric patients span a wide age range, from newborn to adolescents and all have unique needs and requirements. -
Brochure Packaging Solutions for Auto- Injectables
Almac has the flexibility to meet your complex kit assembly outsourcing requirements from low volume, manual kitting through to high volume, semi-automated processing to meet the needs of larger scale commercial market demands. -
Brochure Commercial Packaging Solutions
Meeting your commercial needs, we provide a wide range of customised commercial services from supporting your product launch, manufacturing and/or packaging your drug product, to securing your supply chain with global serialisation solutions.
In line with regulatory compliance, our facilities regularly undergo GMP inspections by MHRA, FDA, and HPRA. We hold GMP certificates enabling GMP development, manufacture, and packaging of products, as well as flexible GMP specific floorspace. Pre-qualified amenities within our floorspace include, power, compressed air, purified water, and RH control.
With over 55 years’ experience and commercial facilities in the UK, US and EU, our global reach and local expertise provides flexible, quality led commercial solutions from orphan drug launches to ongoing high volume commercial product manufacture, packaging and supply.
-
Brochure Commercial Manufacturing Solutions
Commercial manufacturing: At Almac Pharma Services, we specialise in providing comprehensive solutions for commercial pharmaceutical drug manufacture.
With 55+ years of experience and a commitment to excellence, we are your trusted partner in bringing life-saving medications to patients worldwide.We understand the complex and evolving landscape of pharmaceutical manufacturing. Whether it’s scaling up from clinical trials or optimising manufacturing processes, we are here to guide you every step of the way.
-
Brochure Almac Pharma Services’ Commercial Manufacturing Expansion
Insights into our Custom-built GMP commercial manufacturing facility measuring 100,000ft2 / 9,300m2 -
Datasheet Controlled Release Drug Delivery and Manufacture
With over 55 years of experience, Almac combines expertise in oral dosage form
development and controlled release technologies to produce well-characterised and
reproducible dosage forms that release within specifications. -
Datasheet Potent Processing and Manufacture
We follow rigorous containment protocols to protect both our employees and the environment, ensuring both safety and compliance at every step. Almac develops and manufactures oral dosage formulations containing high potency API from our state-of-the-art non-GMP and GMP facilities, with batch sizes ranging from gms to tons. -
Brochure Specialised Packaging Solutions
With more than 55 years’ experience, we offer a wide range of flexible specialised packaging solutions, including innovative ATMP packaging, to meet all your product launch and ongoing commercial supply needs.Streamline your pharmaceutical product launch and distribution with Almac's expert services
-
Brochure Bioavailability Enhancement Solutions
At Almac, we bridge the gap between drug substance and drug product. From pre-formulation all the way to GMP manufacture, trust Almac to transform your drug product’s potential into a clinical-ready solution. -
Brochure Welcome to Almac Group
The Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. -
Brochure Expert Analytical Solutions
Almac employs over 700 highly skilled analytical scientists across five global locations working in regulatory-approved GMP laboratories. With 55+ years of experience, our expert teams develop 1,000+ analytical methods and validate 250+ methods annually. Drawing upon an extensive range of analytical technology, combined with a wealth of analytical knowledge, we can add real value to your drug development and commercialisation programs.